Cloover

Critical infrastructure underpins modern life—power grids, healthcare systems, manufacturing plants, and transportation networks that keep our world running. Yet these cyber-physical systems face escalating threats that can disrupt essential services and endanger public safety. Claroty exists to secure these vital connections, empowering organizations across industrial, healthcare, public sector, and commercial environments to protect their Extended Internet of Things (XIoT) assets. The company's platform delivers comprehensive visibility, threat detection, and vulnerability management, ensuring that operational technology, healthcare devices, and enterprise IoT remain resilient against cyber attacks. As digital transformation accelerates, the convergence of IT and operational technology creates new vulnerabilities that traditional security tools cannot address. Claroty's purpose-built solutions provide deep protocol coverage and AI-driven analytics to detect both known and unknown threats before they cause damage. By securing mission-critical infrastructure across healthcare delivery, manufacturing, energy, and government operations, Claroty enables life to continue uninterrupted—protecting not just systems, but the people and communities who depend on them every single day.

Clario is a leading healthcare research and technology company that generates high-quality clinical evidence for pharmaceutical, biotechnology, and medical device partners. Formerly known as ERT and Bioclinica, Clario brings over 50 years of expertise to clinical trial management. The company fuses deep scientific knowledge with global scale to deliver the broadest endpoint technology platform available. Clario has supported nearly 900 regulatory approvals across 19,000 studies spanning almost 600 indications, demonstrating a proven track record of accelerating drug development and reducing trial risk. Clario's comprehensive solutions span cardiac safety, electronic clinical outcome assessments (eCOA), medical imaging, precision motion, respiratory endpoints, and clinical adjudication. The company supports decentralized, hybrid, and site-based trials with advanced cloud-native technologies and AI-powered tools. With a presence in more than 80,000 sites worldwide, Clario's science-informed approach ensures the richest evidence possible for life-changing therapies. Their mission is to transform lives by unlocking better evidence, uniting clinical science, innovative technology, and global expertise to bring new treatments to patients faster.

Clarifai is a full-stack AI platform founded in 2013, built to help organisations transform unstructured image, video, text, and audio data into actionable insights. The platform covers the entire AI lifecycle - from data preparation and model training through to production deployment and monitoring - and supports computer vision, natural language processing, and audio analysis. Clarifai gained early recognition by winning the top five places in image classification at the ImageNet 2013 competition and has since been named a leader in Forrester's New Wave Computer Vision report. The platform serves over 400,000 users across 170+ countries, delivering billions of predictions and providing access to more than one million AI models. Clients include Amazon, Siemens, NVIDIA, Canva, Vimeo, and OpenTable. Clarifai has raised $100 million in total reported funding, including a $60 million Series C round. On the technical side, the platform spans MLOps, large language models, AI compute orchestration, and edge deployment via its Local Runners feature. Its inference capabilities extend to large-scale models, with a reported benchmark of 544 tokens per second using the GPT-OSS-120B model. The AI Compute Orchestration layer is designed to manage and coordinate compute resources across AI workloads at scale.

At Clarivate, we are united by a shared belief that human ingenuity has the power to solve the world's most complex challenges. Our global team of researchers, data scientists, and industry experts work together to provide transformative intelligence that accelerates innovation across academia, healthcare, and intellectual property. We foster a culture of collaboration where diverse perspectives are valued and every voice matters—ensuring we deliver insights our customers can trust. We believe in pushing boundaries while maintaining integrity and accountability in everything we do. Our team members thrive in an environment that encourages continuous learning, creative problem-solving, and meaningful impact—from helping researchers advance scientific discovery to supporting life sciences companies develop life-saving treatments. We celebrate our collective achievements through team-building activities, community volunteering, and recognition programs that honor both individual contributions and collaborative success.

Harver is the industry-leading hiring solution helping organizations make better talent decisions, faster. Rooted in over 35 years of rich data insights backed by industrial-organizational psychology and cognitive science, Harver delivers a suite of predictive assessments and automated solutions that enable companies to engage, hire, and develop the right talent quickly and fairly. With over 100 million candidates processed and more than 1,300 customers worldwide, Harver empowers talent teams to optimize every stage of the hiring journey. The company's trusted, science-backed platform includes assessments, video interviews, scheduling, and reference checking - all designed to reduce bias, improve candidate experience, and deliver data-driven insights that strengthen hiring outcomes across the employee lifecycle. Having processed over 100 million candidates, Harver provides trusted, flexible, and adaptable solutions that help organizations take the sure path to the right talent.

Founded in 2011, Claritas Rx emerged from a critical gap in the specialty pharmaceutical industry: manufacturers lacked visibility into what happened to patients after prescriptions left their offices. In complex specialty networks where medications could travel through specialty distributors, pharmacies, and hub services, biopharma companies were essentially flying blind - unable to see the real-world barriers that prevented patients from starting or staying on life-changing treatments. Our founders realized that without this visibility, manufacturers couldn't optimize patient access, improve adherence, or truly understand therapy performance in the real world. Today, Claritas Rx has grown from a small channel data consultancy into a pioneering healthcare technology company that illuminates the complete patient journey. Our intelligent Claritas Rx Ascend platform unifies fragmented healthcare data from specialty pharmacies, distributors, and hubs, then applies AI and predictive modeling to identify barriers before they disrupt care. With 95% patient match accuracy and the ability to increase fill rates by 20% in complex cases, we've transformed from data aggregators to trusted partners who help rare disease and specialty brands remove access barriers - ensuring patients not only start therapy but stay on it. From our headquarters in South San Francisco, our team of patient journey experts continues pushing the boundaries of what's possible in specialty analytics, because we believe progress means every patient journey counts.